156 related articles for article (PubMed ID: 29985265)
1. Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.
Zhang Y; Sivay MV; Hudelson SE; Clarke W; Breaud A; Wang J; Piwowar-Manning E; Agyei Y; Fogel JM; Hamilton EL; Selin A; MacPhail C; Kahn K; Gómez-Olivé FX; Hughes JP; Pettifor A; Eshleman SH
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):315-322. PubMed ID: 29985265
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
Grant-McAuley W; Fogel JM; Galai N; Clarke W; Breaud A; Marzinke MA; Mbwambo J; Likindikoki S; Aboud S; Donastorg Y; Perez M; Barrington C; Davis W; Kerrigan D; Eshleman SH
PLoS One; 2020; 15(10):e0240890. PubMed ID: 33119663
[TBL] [Abstract][Full Text] [Related]
3. Natural control of HIV infection in young women in South Africa: HPTN 068.
Sivay MV; Fogel JM; Wang J; Zhang Y; Piwowar-Manning E; Clarke W; Breaud A; Blankson J; Hamilton EL; Kahn K; Selin A; Gomez-Olive FX; MacPhail C; Hughes JP; Pettifor A; Eshleman SH
HIV Clin Trials; 2018 Oct; 19(5):202-208. PubMed ID: 30522410
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.
Chen I; Connor MB; Clarke W; Marzinke MA; Cummings V; Breaud A; Fogel JM; Laeyendecker O; Fields SD; Donnell D; Griffith S; Scott HM; Shoptaw S; del Rio C; Magnus M; Mannheimer S; Wheeler DP; Mayer KH; Koblin BA; Eshleman SH
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):446-52. PubMed ID: 25861015
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).
Parikh UM; Kiepiela P; Ganesh S; Gomez K; Horn S; Eskay K; Kelly C; Mensch B; Gorbach P; Soto-Torres L; Ramjee G; Mellors JW;
PLoS One; 2013; 8(4):e59787. PubMed ID: 23585827
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.
Zhang Y; Fogel JM; Guo X; Clarke W; Breaud A; Cummings V; Hamilton EL; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort T; Eshleman SH
AIDS; 2018 Jun; 32(10):1301-1306. PubMed ID: 29794492
[TBL] [Abstract][Full Text] [Related]
7. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
Grant-McAuley W; Piwowar-Manning E; Clarke W; Breaud A; Zewdie KB; Moore A; Ayles HM; Kosloff B; Shanaube K; Bock P; Meehan SA; Maarman G; Fidler S; Hayes R; Donnell D; Eshleman SH;
J Int AIDS Soc; 2023 Oct; 26(10):e26179. PubMed ID: 37886843
[TBL] [Abstract][Full Text] [Related]
8. HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).
Fogel JM; Wilson EA; Piwowar-Manning E; Breaud A; Clarke W; Petropoulos C; Moore A; Fraser C; Kosloff B; Shanaube K; van Zyl G; Scheepers M; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D; Eshleman SH;
J Int AIDS Soc; 2022 Jul; 25(7):e25941. PubMed ID: 35775502
[TBL] [Abstract][Full Text] [Related]
9. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
[TBL] [Abstract][Full Text] [Related]
10. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).
Fogel JM; Wang L; Parsons TL; Ou SS; Piwowar-Manning E; Chen Y; Mudhune VO; Hosseinipour MC; Kumwenda J; Hakim JG; Chariyalertsak S; Panchia R; Sanne I; Kumarasamy N; Grinsztejn B; Makhema J; Pilotto J; Santos BR; Mayer KH; McCauley M; Gamble T; Bumpus NN; Hendrix CW; Cohen MS; Eshleman SH
J Infect Dis; 2013 Nov; 208(10):1624-8. PubMed ID: 23908493
[TBL] [Abstract][Full Text] [Related]
11. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075.
Palumbo PJ; Zhang Y; Clarke W; Breaud A; Sivay M; Cummings V; Hamilton EL; Guo X; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH
Int J Infect Dis; 2021 Mar; 104():465-470. PubMed ID: 33440260
[TBL] [Abstract][Full Text] [Related]
12. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
13. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.
Lippman SA; Mooney AC; Puren A; Hunt G; Grignon JS; Prach LM; Gilmore HJ; Truong HM; Barnhart S; Liegler T
BMC Infect Dis; 2020 Mar; 20(1):248. PubMed ID: 32216752
[TBL] [Abstract][Full Text] [Related]
14. HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074.
Palumbo PJ; Zhang Y; Fogel JM; Guo X; Clarke W; Breaud A; Richardson P; Piwowar-Manning E; Hart S; Hamilton EL; Hoa NTK; Liulchuk M; Anandari L; Ha TV; Dumchev K; Djoerban Z; Hoffman I; Hanscom B; Miller WC; Eshleman SH
PLoS One; 2019; 14(10):e0223829. PubMed ID: 31600343
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 diversity among young women in rural South Africa: HPTN 068.
Sivay MV; Hudelson SE; Wang J; Agyei Y; Hamilton EL; Selin A; Dennis A; Kahn K; Gomez-Olive FX; MacPhail C; Hughes JP; Pettifor A; Eshleman SH; Grabowski MK
PLoS One; 2018; 13(7):e0198999. PubMed ID: 29975689
[TBL] [Abstract][Full Text] [Related]
16. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Manasa J; Lessells RJ; Skingsley A; Naidu KK; Newell ML; McGrath N; de Oliveira T;
PLoS One; 2013; 8(8):e72152. PubMed ID: 23991055
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.
Dagnra AY; Vidal N; Mensah A; Patassi A; Aho K; Salou M; Monleau M; Prince-David M; Singo A; Pitche P; Delaporte E; Peeters M
J Int AIDS Soc; 2011 Jun; 14():30. PubMed ID: 21663632
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
Lima YA; Reis MN; Cardoso LP; Stefani MM
BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
Masquelier B; Costagliola D; Schmuck A; Cottalorda J; Schneider V; Izopet J; Calvez V; Descamps D; Poggi C; Brun-Vézinet F;
J Med Virol; 2005 Aug; 76(4):441-6. PubMed ID: 15977249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
